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Leukocyte-polytetrafluoroethylene interaction enhances
proliferation of vascular smooth muscle cells via tumor necrosis
factor-a secretion
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Leukocyte-polytetrafluoroethylene interaction enhances proliferation
of vascular smooth muscle cells via tumor necrosis factor-a secretion.
Intimal hyperplasia of vascular smooth muscle cells (VSMC) at the venous
anastomosis of arteriovenous grafts represents the most common cause of
vascular access failure in hemodialysis patients. Upstream release of
growth factors from leukocytes activated by adhesion to the graft material
may play a role in this lesion. We evaluated the effect of interaction of
peripheral blood mononuclear cells (PBMC) with polytetrafluoroethylene
(PTFE) on proliferation of VSMC. Vascular smooth muscle cell prolifer-
ation was significantly increased by conditioned media from human PBMC
incubated with PTFE. Peripheral blood mononuclear cell adhesion to
PTFE could not be antagonized by the 13i integrin ligand-containing
peptide GRGDSP, but was attenuated by EDTA consistent with 132
integrin-mediated adhesion. Soluble scavenger receptor ligands at high
concentrations had no effect on adhesion to PTFE excluding any contrib-
utoly role of scavenger receptors in this interaction. Neutralizing antibod-
ies to TNF-a significantly attenuated the mitogenic effect of PBMC/PTFE
conditioned media and a marked increase in TNF-cs secretion by PBMC
on PTFE was detected by ELISA. These studies demonstrate that PBMC
interaction with PTFE can promote proliferation of VSMC via increased
production of TNF-a and perhaps other cytokines. Leukocyte interaction
with PTFE causing enhanced secretion of TNF-a and consequent VSMC
proliferation may account for the development of venous intimal hyper-
plasia in hemodialysis patients with arteriovenous grafts.
Angioaccess failure is a major source of morbidity in hemodi-
alysis patients and accounts for at least 15% of their hospitaliza-
tions [1—3]. The majority of access failure occurs in patients with
arteriovenous grafts made of polytetrafluoroethylene (PTFE),
which represent the most common form of angioaccess in hemo-
dialysis patients in the United States [4—101. Arteriovenous graft
revision has a high failure rate and is expensive [2]. Although
some studies have suggested hypercoagulable states as a cause of
angioaccess failure [11], this hypothesis has two weaknesses: (1)
anticoagulation is unable to prevent arteriovenous graft failure in
a majority of patients and (2) the most common cause of PTFE
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arteriovenous graft failure is not hypercoagulable states, but
instead intimal hyperplasia at the venous anastomosis [5, 12].
Hence, graft thrombosis in the majority of patients is due to
venous outflow stenosis that eventually diminishes blood flow
sufficiently to allow thrombosis to occur. However, the pathogen-
esis of this lesion in hemodialysis patients with PTFE grafts is not
well understood, as reviewed at length elsewhere [5]. Pathologi-
cally, the lesion has been shown to consist of vascular smooth
muscle cell (VSMC) proliferation with consequent lumenal nar-
rowing [12]. Hemodynamic forces have been postulated to cause
this lesion in patients with arteriovenous grafts, presumably as a
consequence of turbulence at the venous anastomosis. Arterio-
venous fistulas have high turbulence as well and develop stenosis
at venous bifurcations, where turbulence is maximal. These find-
ings suggest a role for turbulence in the development of intimal
hyperplasia, although the incidence of fistula stenosis is substan-
tially less than in grafts, and reducing turbulence by changing from
end-to-side to end-to-end anastomosis has unfortunately not
decreased the incidence of intimal hyperplasia [7]. An additional
hypothesis is that there may be upstream release of growth factors
released by platelets aggregating at needle puncture sites. Al-
though needle puncture is common to both fistulas and grafts, and
while grafts that have never been used can develop venous intimal
hyperplasia as well, this tends to occur at a much slower rate and
hence a role for platelets in intimal hyperplasia is certainly
plausible [5]. As Swedberg et al have pointed out, this lesion can
also occur in the distal anastomosis of arterial bypass grafts (in
which there is no needle puncture) [12]. While undoubtedly these
variables all could contribute to intimal hyperplasia, they do not
clearly account for the disproportionate failure of arteriovenous
grafts, suggesting that one or more factors related to the graft
material itself may play a role.
Activated leukocytes are an important source of VSMC growth
factors such as tumor necrosis factor-alpha (TNF-a), a cytokine
strongly implicated in causing VSMC proliferation in vein grafts,
arterial balloon injury and acute cardiac rejection among other
clinical settings [13—15]. Other investigators have shown that
peripheral blood leukocytes and other cells can adhere to PTFE
with a variety of biological responses [16—19]. PTFE arterio-
venous grafts do not endothelialize in humans; hence, it is
plausible that circulating leukocytes may adhere to the graft
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material and release cytokines upstream of the venous anastomo-
sis, exposing VSMC to growth factors and resulting in intimal
hyperplasia at the venous anastomosis of the graft, though this
hypothesis has not been tested. In the present study we have
evaluated the mechanism by which the interaction between hu-
man peripheral blood mononuclear cells (PBMC) and PTFE used
in arteriovenous grafts may modulate VSMC proliferation.
METHODS
Isolation of peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated
from healthy volunteers using standard methodology [20]. In
brief, whole blood was collected in 2.7% EDTA in a 10:1 (vol/vol)
ratio and mixed 1:1 (vol/vol) with 1-lank's balanced salt solution
(HBSS; GIBCO, Grand Island, NY, USA). The solution was
layered carefully over 15 ml of Ficoll-Paque (Pharmacia) in a 50
ml polypropylene tube and centrifuged at 2,200 rpm for 20
minutes. The interface was collected, diluted with HBSS and
centrifuged at 1,500 rpm for 10 minutes at 4°C. The pellet was
resuspended in centrifuged plasma and centrifuged again at 1,200
rpm for five minutes at 4°C. Cells were then washed three
additional times with HBSS and then resuspended at 106/ml in
serum-free Dulbecco's MEM (DMEM, GIBCO) containing pen-
icillin 50 U/ml and streptomycin 50 jg/ml for use in experiments.
Trypan blue exclusion studies demonstrated> 95% of PBMC to
be viable.
Incubation of peripheral blood mononuclear cells and
preparation of conditioned media
Wells on 96-well plastic culture plates (Becton-Dickinson,
Lincoln Park, NJ, USA) were coated with 50 p1/well of a solution
of polyhydroxyethylmethacrylate (polyHEMA, 1.2 g in 10 ml of
95% ethanol; Sigma Chemical Co., St. Louis, MO, USA) and
dried under a laminar flow hood for 48 hours to produce a
translucent surface, which other investigators have shown does
not allow cell adhesion [21]. The PTFE graft material (Goretex®)
was generously provided by W.L. Gore and Associates, Inc. The
material was cut into discs and carefully secured into the bottom
of selected po1yHEMA coated wells with the remaining poly-
HEMA wells serving as control. Therefore, cells in wells coated
with the nonadhesive substrate poIyHEMA would mimic circulat-
ing leukocytes, while cells in wells coated with po1yHEMA plus a
disc of PTFE would mimic leukocytes interacting with the PTFE
graft material. Suspensions of PBMC at 106/ml in serum-free
DMEM were added to all wells. Plates were incubated at 37°C in
a 95% air 5% CO2 environment for 24 hours. The supernatants
were then collected, centrifuged at 1,500 rpm for 10 minutes and
then filtered using a 0.2 /tm pore diameter syringe filter (Acrodisc;
Gelman Corp, Ann Arbor, Ml, USA). Absence of cells in the
conditioned media (CM) was confirmed by examination with a
hemacytometer. There was no adhesion of PBMC to polyHEMA.
Conditioned media were used either immediately for experiments
or were stored frozen in aliquots at —70°C and defrosted imme-
diately before use.
Vascular smooth muscle cell proliferation studies
Rat aortic smooth muscle cells (herein termed VSMC) were
obtained from American Type Culture Collection (Rockville,
MD, USA; A-lU 1476-CRL) and grown in DMEM containing 50
U/mI penicillin, 50 tg/ml streptomycin and 20% nonheat-inacti-
vated fetal calf serum (FCS; GIBCO) at 37°C in a 95% air, 5%
CO2 environment. For experiments VSMC were detached by
washing with PBS followed by brief exposure to 0.25% trypsin/
EDTA solution. Cells were seeded onto 96-well tissue culture
plates (Becton Dickinson) at 5 X 103/ml in DMEM containing 2%
nonheat-inactivated FCS and incubated at 37°C for six hours to
allow attachment. The media was then removed and replaced with
DMEM containing 2% nonheat-inactivated FCS alone or 2%
nonheat-inactivated FCS plus CM from PBMC incubated on
poIyHEMA alone or po1yHEMA/PTFE at valying concentrations.
After 72 hours cells were washed with phosphate-buffered saline,
detached using 0.25% trypsin/EDTA solution and counted using a
hemacytometer.
Additionally, to determine whether uremic sera might modu-
late the VSMC response to PBMC/PTFE CM, VSMC prolifera-
tion studies with PBMC/po1yHEMA and PBMC/PTFE CM were
carried out using non-heat inactivated sera collected predialysis
and pooled from three patients on chronic hemodialysis at 2%
concentration in place of FCS.
Vascular smooth muscle cell proliferation studies using other
conditioned media
Additional studies were carried out using the macrophage cell
line J774.16 to provide a comparison with PBMC. Conditioned
media were prepared from J774.16 macrophages incubated on
plates coated with polyHEMA alone or po1yHEMA-coated plates
containing discs of PTFE in identical fashion as for PBMC.
VSMC proliferation studies were then carried out as described
above.
Peripheral blood mononuclear cell adhesion studies and role of
integrins and scavenger receptors
Adhesion studies were carried out as described previously with
modification [22]. Ninety-six-well tissue culture plates were coated
with po1yHEMA and selected wells had discs of PTFE placed at
the bottom of the wells as described above. Other investigators
have shown that leukocyte adhesion to PTFE takes place via 2
integrins [17], although leukocytes also express scavenger recep-
tors that have been shown to act as adhesion molecules on other
substrates [22]. To evaluate the respective roles of integrins and
scavenger receptors in adhesion to PTFE in the present culture
conditions, PBMC were presuspended in DMEM alone or
DMEM containing the /3 integrin ligand-eontaining peptide
Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP, Peninsula, Belmont, CA,
USA) at 25 g/ml for 30 minutes at 37°C before seeding onto
polyHEMA-coated tissue culture plates with or without PTFE.
lntegrin-mediatcd adhesion is calcium-dependent. Hence, in
other experiments PI3MC were washed three times with calcium-
free PBS and then suspended in calcium-free PBS pH 7.4
containing 5 mvt EDTA. Cells were then seeded onto poIyHEMA
alone or polyl IEMA-coated wells containing PTFE. It is plausible
that scavenger receptors could play a role in adhesion to PTFE.
To determine the role of scavenger receptors in adhesion to PTFE
the scavenger receptor ligands polyinosinic acid and dextran
sulfate were used as previously described [22]. PBMC were
suspended in serum-free DMEM alone or DMEM containing
polyinosinic acid at 10, 25 or 50 jg/ml or dextran sulfate at 50, 100
and 1,000 jig/mI. PBMC were preincubated with these agents for
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30 minutes at 37°C keeping the cells gently agitated. Peripheral
blood mononuclear cell suspensions were then added onto poly-
HEMA alone or polyHEMA/PTFE wells, and after 60 minutes in
all experiments discs were removed from the wells and adherent
cells counted using a hemacytometer. For each set of experimen-
tal conditions a control sample of cells treated under each of the
preincubation conditions and seeded onto po1yHEMA coated
plates without PTFE was utilized.
To directly visualize leukocyte adhesion to PTFE, which is
opaque, J774.16 macrophages (which are larger and more readily
visualized than PBMC) were incubated with PTFE fibers in
polyHEMA-coated wells. After 60 minutes the fibers were care-
fully removed, placed on glass slides with a drop of media,
overlaid with a coverslip and examined via phase contrast micros-
copy. This method allows the cells to be easily visualized adhering
to and spreading out on the PTFE fibers in the plane perpendic-
ular to the slide surface.
Role of tumor necrosis factor-a in vascular smooth muscle cell
proliferation
Tumor necrosis factor-a (TNF-a) is secreted in large quantities
by stimulated PBMC and is strongly implicated in mediating
VSMC proliferation in a variety of settings including vein grafts,
arterial balloon injury and acute cardiac rejection, among others
[13—15]. It is thus plausible that enhanced VSMC proliferation in
our in vitro system could be due to secretion of TNF-a by PBMC.
Aliquots of CM from PTFE-incubated PBMC were incubated
with neutralizing antibodies to TNF-a (10 jig/mI, Genzyme) or an
irrelevant antibody at 10 jig/mI or with no antibody for 60 minutes
at 37°C. Aliquots of CM were then diluted in DMEM to achieve
a final concentration of 10% and 2% nonheat inactivated FCS.
Vascular smooth muscle cells were then incubated with these
media and cell proliferation studies carried as described above. In
other experiments, VSMC proliferation studies were carried out
in media with 2% nonheat inactivated FCS plus varying concen-
trations of human TNF-a (Sigma).
ELISA measurements for tumor necrosis factor-a
Tumor necrosis factor-a concentrations in supernatants from
PBMC incubated on po1yHEMA alone or PTFE were measured
by using Quantikine human TNF-a Immunoassay Kit (R & D
Systems, Inc., Minneapolis, MN, USA). This assay employs a
sandwich enzyme immunoassay technique. A monoclonal anti-
body specific for human TNF-a was precoated onto a microtiter
plate. Human TNF-a standards and samples were pipetted into
the wells. After washing, an enzyme-linked polyclonal antibody
specific for TNF-a was added to the wells. Following a wash a
substrate solution was added to the wells and absorbance mea-
sured using a Beckman ELISA plate reader. TNF-a concentra-
tions were calculated by comparison with a simultaneously gen-
erated standard curve for human TNF-a and were recorded as
pg/mI.
Statistical analysis
All data are reported as mean SuM and all experiments were
carried out in triplicate. Statistical comparisons between two
groups were carried out using the Student's unpaired t-test.
Comparisons between multiple groups were carried out using
Fig. 1. Vascular smooth muscle cell (VSMC) proliferation following
incubation with conditioned media from peripheral blood mononuclear
cells (PBMC)/polytetrafluoroethylene (PTFE) interaction. VSMC were
seeded Onto tissue culture plates, and after six hours the media was
changed to DMEM containing 2% nonheat-inactivated FCS with or
without conditioned media from PBMC incubated on the nonadhesive
substrate polyHEMA alone or on PTFE as described in the Methods
section. After 72 hours cells were trypsinized and counted using a
hemacytometer. Results are from 4 experiments carried out in triplicate.
Statistical comparisons carried out using ANOVA with Newman-Keuis
multiple range testing. Abbreviations are: C, control, no conditioned
media; PH, conditioned media from PBMC in p0JyHEMA coated wells
without PTFE; PT, conditioned media from PBMC in poIyHEMA-coated
wells containing PTFE. *p < 0.05 compared to PH 10%; **< 0.01
compared to PH 25%.
analysis of variance with Newman-Keuls multiple range testing.
Statistical significance was defined as a P value of <0.05.
RESULTS
Vascular smooth muscle cell proliferation with PBMC/PTFE
conditioned media
Figure 1 illustrates the results of VSMC proliferation studies. A
small though nonsignificant increase in VSMC proliferation was
observed for VSMC incubated with 5% CM from PBMC that had
interacted with PTFE compared to CM from PBMC on poly-
HEMA alone. However, at 10% concentration of CM a significant
increase in VSMC proliferation was observed (10% PBMC/PTFE,
12,500 700 cells; 10% PBMC/po1yHEMA, 8,700 650, P <
0.05, N = 4 experiments carried out in triplicate). A greater
increase was seen using 25% CM (25% PBMC/PTFE, 16,130
1,230 cells; PBMC/polyHEMA, 10,500 470, P < 0.01, N = 4
experiments in triplicate). These data demonstrate that PBMC/
PTFE interaction enhances the proliferation of VSMC.
Table 1 summarizes the results of VSMC proliferation studies
with PBMC/p0IyHEMA and PBMC/PTFE CM using pooled
uremic sera in place of FCS. Substitution of FCS with uremic sera
did not appear to alter the mitogenic effect of PBMC/PTFE on
VSMC.
Vascular smooth muscle cell proliferation with conditioned
media from J774.16 macrophages incubated with
polyetrafluoroethylene
As illustrated in Figure 2, a dose-response relationship can be
seen for VSMC incubated with CM from J774.16 incubated with
I
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Condition Cell number P value
Control 9,200 400 —
5% PBMC/PH CM 10,400 800 NS
5% PBMC/PTFE CM 12,400 400 <0.05
10% PBMC/PH CM 10,800 500 NS
10% PBMC/PTFE CM 16,800 1,060 <0.01'
Vascular smooth muscle cell (VSMC) proliferation studies were carried
out using uremic sera (non-heat inactivated) pooled from 3 patients on
chronic hemodialysis in place of fetal calf serum (FCS) with or without
conditioned media (CM) as described in the Methods section (N = 4).
Statistical comparisons carried out using analysis of variance with New-
man-Keuls multiple range testing. Abbreviations are:
a Represents comparison with both control as well as 10% PBMC/PH
PBMC/PH CM, conditioned media collected from PBMC incubated on
p0IyHEMA-coated plates without PTFE; PBMC/PTFE CM, conditioned
media collected from PBMC incubated on polyHEMA-coated plates
containing discs of PTFE.
PTFE that is comparable to the findings with CM from PBMC.
VSMC proliferation at these concentrations was greater with CM
from PTFE-incubated macrophages compared with macrophages
on po1yHEMA alone. These results with the J774.16 CM are
consistent with the PBMC CM findings in that mononuclear cell
interaction with PTFE appears to increase VSMC proliferation.
Peripheral blood mononuclear cell adhesion to
polytetrafluoroethylene and role of integrins and scavenger
receptors
Figure 3A is a representative light photomicrograph of PTFE
fibers after incubation with J774.16 macrophages and washing
(original magnification x200). On the side of the fiber perpen-
dicular to the slide surface many of these cells can be seen
adhering to and spreading out on the PTFE surface. Figure 3B is
a higher magnification view (original magnification x600) of two
of these cells illustrating how they spread out on the PTFE
surface. Figure 4 illustrates the results of PBMC adhesion studies.
In these experiments 117,300 4,700 PBMC adhered to each
PTFE disc. There was no adhesion to po1yHEMA-coated surfaces
(data not shown). Preincubating PBMC with the f3 integrin
ligand-containing peptide GRGDSP did not significantly attenu-
ate PBMC adhesion to PTFE (115,300 2,900 cells, P = NS, Fig.
4). However, removal of calcium from the incubation media by
use of calcium-free media plus 5 m'vi EDTA significantly dimin-
ished adhesion of PBMC to PTFE (22,100 2,100 cells, P < 0.01,
N = 3 experiments carried out in triplicate, Fig. 4). These findings
are consistent with those of other investigators in that they suggest
that 2 integrins mediate adhesion of PBMC to PTFE [17].
While scavenger receptors play an important role in leukocyte
adhesion to other substrates such as plastic, it is unknown whether
scavenger receptors could play any significant role in PBMC
adhesion to PTFE. As shown in Figure 5 preincubating PBMC
with the scavenger receptor ligands dextran sulfate and polyi-
nosinic acid, even at high concentrations, did not attenuate PBMC
adhesion to PTFE. These data demonstrate that scavenger recep-
tor interaction seems unlikely to play any significant role in PBMC
adhesion to PTFE.
C PH PT PH PT
10% 10% 25% 25%
Fig. 2. Vascular smooth muscle cell (VSMC) proliferation studies with
conditioned media (CM) from J774.16 macrophages incubated with
polytetrafluoroethylene (PTFE). Conditioned media were collected from
J774.16 macrophages incubated on poIyHEMA alone or poIyHEMA-
coated plates containing PTFE discs. The VSMC were incubated with
media alone or media containing the respective CM and proliferation
measured as described in Methods section. Data are from 4 experiments
carried out in triplicate. Abbreviations are: C, control, no conditioned
media; PH, conditioned media from J774.16 macrophages in polyHEMA
coated wells without PTFE; PT, conditioned media from J774.16 macro-
phages in poIyHEMA-coated wells containing PTFE. *p < 0.05 compared
to PH 10%; ** < 0.01 compared to PH 25%.
Effect of neutralizing antibodies to tumor necrosis factor-a on
vascular smooth muscle cell proliferation
Figure 6 illustrates the results of VSMC proliferation studies
carried out using CM preincubated with neutralizing antibodies to
TNF-a. As this Figure illustrates, the mitogenic effect of PBMC/
PTFE CM was significantly attenuated by neutralizing antibodies
to TNF-cs (control, 8,500 280 cells; 10% PBMC/PTFE CM,
12,540 cells, P < 0.05; 10% PBMC/PTFE/anti-TNF-a, 9,500
640 cells, P < 0.05, N = 4 experiments carried out in triplicate).
The mitogenic effect of PBMC/PTFE CM was not attenuated by
preineubation with an irrelevant antibody (data not shown).
Tumor necrosis factor-a production following peripheral blood
mononuclear cell interaction with polytetrafluoroethylene
Peripheral blood mononuclear cell interaction with PTFE led
to a marked increase in TNF-a levels in the CM compared to
PBMC incubated with polyHEMA alone (control PBMC [poly-
HEMA], 1.3 0.3 pg/ml; PBMC/PTFE, 1,150 100 pg/mI, P <
0.01, N = 3). These data, which are illustrated in Figure 7,
demonstrate that PBMC generation of TNF-a is greatly enhanced
by interaction with PTFE compared to being kept in suspension.
Direct effect of human tumor necrosis factor-a on vascular
smooth muscle cell proliferation
As summarized in Table 2, human TNF-cs exerted a concentra-
tion-dependent effect on VSMC proliferation. The earliest statis-
tically significant effect on proliferation could he detected at
incubation with a concentration of 10 pg/mi. Based on the
concentrations of TNF-a detected by ELISA and these data, the
dilutions of CM used in the present experiments contained
concentrations of TNF-a correlating with enhanced VSMC pro-
liferation.
Table 1. Impact of uremic sera on VSMC proliferation with PBMC/
PTFE conditioned media ci)
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Fig. 3. Representative light photomicrographs
of J774.16 macrophages adherent to
polytetrafluoroethylene (PTFE). J774.16
niacrophages (used because of their larger size
and hence easier visualization) were incubated
with PTFE fibers in polyHEMA coated wells
for 60 minutes at 37°C, removed from the wells,
placed on glass microscope slides with a drop of
media, overlaid with a coverslip and examined
using phase contrast microscopy. (A) Many cells
can be seen adhering and spreading out over
the perpendicular surface of the PTFE material
(original magnification, X200). (B) A higher
magnification view (original magnification,
X600) of two of the cells adhering and
spreading on the PTFE material.
DISCUSSION
One of the most troubling problems in hemodialysis patients is
maintaining long-term functioning angioaccess, particularly in
those who have arteriovenous PTFE grafts. In many patients,
though, this is the preferred form of angioaccess because of poor
vasculature and other conditions [231. In the United States the
placement of arteriovenous grafts made of PTFE far exceeds the
creation of arteriovenous fistulas and vascular access-related
problems account for at least 15% of hospital admissions in these
patients. While some studies have suggested a role for hyperco-
agulable states in access thrombosis and while undoubtedly this
does contribute to access failure in some patients, it has been
shown that the most common reason for failure of arteriovenous
grafts is the development of intimal hyperplasia at the venous
anastomosis of the grafts [5, 121. The hyperplastic cells in the
intimal hyperplastic lesion have been shown to be VSMC [12, 241.
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Fig. 4. Role of integrins in peripheral blood mononuclear cell (PBMC)
adhesion to polytetrafluoroethylene (PTFE). The PBMC were preincu-
bated with an integrin ligand-containing peptide GRGDSP at 25 jrml for
30 minutes as described in the Methods section. Other aliquots of PBMC
were washed in calcium and magnesium-free PBS and were then sus-
pended in calcium and magnesium-free PBS containing 5 mivi EDTA. The
PBMC were then seeded onto p0IyHEMA coated wells containing PTFE
discs and adhesion studies carried Out as described in the Methods section.
Data are from 3 experiments carried out in triplicate. Statistical compar-
isons carried Out using ANOVA with Newman-Keuls multiple range
testing. *D < 0.01 compared to control.
Fig. 5. Role of scavenger receptors in peripheral blood mononuclear cell
(PBMC) adhesion to polytetrafluoroethylene (PTFE). The PBMC were
presuspended in media alone (LI) or media containing either polyinosinic
acid at 10, 25 and 50 pg/mI (•) or dextran sulfate at 20, 50, 100 and 1,000
pg/mi (). After a 30 minute preincubation, PBMC were seeded onto
wells coated with polyHF.MA or polyHEMA-coated wells containing
PTFE discs. After 60 minutes, adhesion studies were carried out as
described in the Methods section. Data arc from 3 experiments carried out
in triplicate. Statistical comparisons carried out using ANOVA with
Ncwman-Kculs multiple range testing. There were no statistically signifi-
cant differences in adhesion between any of the experimental conditions.
Fig. 6. Role of tumor necrosis factor-alpha (TNF-t) in modulation of
vascular smooth muscle cell (VSMC) growth by peripheral blood mono-
nuclear cell (PBMC)/polytetrafluoroethylene (PTFE) interaction. Condi-
tioned media (CM) were collected from PBMC that were incubated with
PTFE as described in the Methods section. Aliquots were then incubated
with or without neutralizing antibodies to TNF-cs (10 sg/ml) or an
irrelevant antibody (10 pg/mI) for 60 minutes at 37CC. VSMC were then
incubated with DMEM containing 2% nonheat-inactivated FCS with or
without 10% CM from the above experimental conditions and VSMC
proliferation measured as described in the Methods section. Data are
from 4 experiments carried Out in triplicate. Statistical comparisons
carried out using ANOVA with Newman-Keuls multiple range testing.
Abbreviations are: C, control, no conditioned media; PH, conditioned
media from PBMC in polyHEMA coated wells without PTFE discs; PT,
conditioned media from PBMC in polyHEMA-coated wells containing
PTFE discs; PT-aTNF, conditioned media from PBMC in p0IyHEMA-
coated wells containing PTFE discs that were incubated with neutralizing
antibodies to TNF-a prior to VSMC proliferation studies. < 0.05
compared to PH 10%; ** < 0.05 compared to PT 10%.
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prolonging arteriovenous graft function, except perhaps in those
patients with hypercoagulable states such as that associated with
the antiphospholipid antibody syndrome. For the majority of
hemodialysis patients such therapies are ineffective.
Tumor necrosis factor-a is a well-known VSMC mitogen that
has been demonstrated to play a role in VSMC proliferation in a
variety of vascular pathologies [13—15] and PBMC are a rich
source of this cytokine. The present study demonstrates that
PBMC adhesion to PTFE markedly enhances the generation of
TNF-a compared to nonadherent PBMC, and promotes the
proliferation of VSMC. We were able to attenuate the mitogenic
effect of the conditioned media using neutralizing antibodies to
TNF-a and found a marked increase in TNF-a secretion by
PBMC that had interacted with the PTFE material using ELISA.
Hence, this study suggests a potential mechanism by which intimal
hyperplasia at the venous anastomosis of arteriovenous grafts may
develop, namely, circulating leukocytes may adhere to this graft
material and become activated to secrete TNF-a and perhaps
other cytokines that get carried downstream where they can hind
to receptors on VSMC at the venous anastomosis and increase
their proliferation. However, it is likely that, if this indeed
occurred in vivo, it would best be regarded as one of several
variables contributing to the development of this lesion along with
turbulence, platelet adhesion at needle puncture sites and other
factors with suspected roles in this disorder.
Prior reports have not excluded a potential role for scavenger
receptor interaction in this process. Leukocytes express scavenger
However, no satisfactory hypothesis exists to account for why
artcriovcnous grafts fail at a higher rate compared to fistulas.
While some studies have shown that certain clinical variables
correlate with early angioaccess failure [9, 10], these studies have
not addressed mechanisms for the disproportionate failure of
arteriovenous grafts. Unfortunately, to date therapeutic maneu-
vers such as systemic anticoagulation have been unsuccessful in
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Fig. 7. Tumor necrosis factor alpha (TNF-a) production by peripheral
blood mononuclear cells (PBMC) exposed to polytetrafluoroethylene
(PTFE). The PBMC were seeded onto wells coated with polyHEMA
(control) or wells coated with poIyHEMA containing a disc of PTFE
(PTFE in figure) as described in the Methods section. After a 24 hour
incubation at 37°C, TNF-a levels in the culture supernatants were
measured using a sandwich enzyme immunoassay technique as described
in the Methods section. Data are from 3 experiments in triplicate and are
expressed as mean SEM pg TNF-a per ml PBMC culture supernatant.
Note that the y axis (TNF-a level) is in a logarithmic format. Statistical
comparison carried out using the Student's unpaired t-test. Control:
PBMC on wells coated with polyHEMA without PTFE; PTFE: PBMC on
poIyHEMA coated wells containing PTFE discs. *p < 0.01.
receptors, and while they appear to play a role mostly in taking up
modified substances such as oxidized LDL, they can also act as
adhesion molecules, as it has been shown, for example, that
leukocyte adhesion to another synthetic surface (plastic) is scav-
enger receptor mediated [25],as is adhesion to oxidized extracel-
lular matrix [22]. While we found significant adhesion of PBMC to
PTFE, we could not antagonize this adhesion using the scavenger
receptor ligands polyinosinic acid and dextran sulfate, even at very
high concentrations. Use of the soluble 13 integrin ligand
GRGDSP did not significantly attenuate adhesion to PTFE while
calcium-free media with EDTA, however, which will inhibit
binding by both f3 and 132 integrins to a ligand-containing
substrate, did attenuate adhesion. Our findings appear to exclude
any significant contribution of scavenger receptors in leukocyte
adhesion to PTFE and suggest that in our system it was predom-
inantly 132 integrin-mediated, consistent with findings of other
investigators. Our findings are also consistent with the observation
that integrin binding to ligand enhances TNF-a production [26],
and based on our VSMC proliferation studies these findings
suggest that this may have important implications for the devel-
opment of venous intimal hyperplasia. Over time the TNF-a
release by leukocytes activated via interaction with PTFE may
expose VSMC at the venous anastomosis to this mitogen, result-
ing in the development of the lesion described by Swedberg et a!
in their pioneering study as suggestive of"... a steadily progres-
sive (rather than episodic) smooth muscle hyperplasia [12].
While PTFE does not endothelialize in humans and in our
experimental protocol we evaluated adhesion directly to the graft
material, in vivo this substrate may be coated with a variety of
plasma proteins and hence only part of the PTFE surface may be
exposed. Alternatively, the major stimulus for PBMC activation
may take place in the early postoperative period, with leukocytes
adhering extensively to the uncoated surface, causing an initial
Concentration
pg/mi Cell number P value
Control 10,000 1,100 —
0.1 11,700 480 NS
1.0 15,200 1,200 NS
10 17,500 3,010 <0.05
100 19,200 750 <0.05
1000 21,300 3,180 <0.01
Vascular smooth muscle cells (VSMC) were seeded onto 96-well plates
and incubated in 2% nonheat inactivated fetal calf serum (FCS) with
varying concentrations of human tumor necrosis factor alpha (TNF-o) and
cell counts determined as described in the Methods section (N =3).
Statistical analysis was carried out using analysis of variance with New-
man-Keuls multiple range testing. P values correspond to comparison with
control.
strong stimulus for VSMC proliferation with this stimulus subse-
quently diminishing yet continuing.
If leukocyte activation and release of VSMC mitogens such as
TNF-c as a consequence of adhesion to PTFE plays a significant
role in the development of venous intimal hyperplasia, then one
can envision a number of approaches that theoretically might be
able to disrupt this sequence of events. The most obvious of these
would consist of somehow modifying the luminal surface of the
PTFE graft to prevent integrin-mediated adhesion and cross-
linking. Indeed, some investigators have shown that modifications
of the PTFE surface can decrease adhesion and can cause some
decrease in TNF-a production [27], though these studies did not
report TNF-cs production by nonadherent cells (by contrast, we
found a large increase in TNF-a production by PBMC on PTFE
compared to those in suspension). While this may appear to be a
logical approach, a surface incapable of allowing integrin-medi-
ated adhesion might pose a risk of serious hemorrhage following
removal of hemodialysis needles from the graft, as platelet
aggregation at sites of injury (needle puncture) is integrin-
dependent. Without any change in the nature of the graft material
itself, an alternative approach might be to modulate the leukocyte
response to the PTFE surface. This might be done by using
soluble 132 integrin ligands or agents that could prevent the cross
linking of integrins. Alternatively, one or more of the subsequent
events after integrin cross linking might be antagonized, such as
tyrosine phosphorylation of some of the proteins comprising focal
adhesion complexes at these sites. Agents that could specifically
inhibit production of TNF-a and other cytokines or the VSMC
response to mitogenic stimuli (perhaps by directly modifying the
VSMC cells at the venous anastomosis by transfection with genes
promoting quiescence) would be theoretical possibilities as well.
These highly speculative approaches would first require in vivo
demonstration of leukocyte generation of TNF-cs in the patho-
genesis of venous intimal hyperplasia in arteriovenous grafts.
In summary, the present study demonstrates that PBMC inter-
action with PTFE promotes the proliferation of VSMC at least in
part due to increased TNF-cx generation. These data support the
hypothesis that arteriovenous graft failure from venous intimal
hyperplasia may be a consequence of leukocyte interaction with
PTFE graft material. Further understanding of this mechanism
might yield more effective medical therapies to prevent angioac-
cess failure in hemodialysis patients with arteriovenous grafts.
Table 2. Direct effect of human TNF-a on VSMC proliferation
Control PTFE
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APPENDIX
Abbreviations used in this article are: VSMC, vascular smooth muscle
cells; PBMC, peripheral blood mononuclear cells; PTFE, polytetrafluoro-
ethylene; TNF-a, tumor necrosis factor-alpha; CM, conditioned media;
polyHEMA, polyhydroxyethylmethacrylate; HBSS, Hank's balanced salt
solution; DMEM, Dulbecco's MEM; FCS, fetal calf serum.
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